KEAP1 and inflammatory bowel disease: Activation of the Nrf2/keap1 signaling pathway could provide an endogenous defence system against cellular oxidative stress and attenuate oxidative damage, making it a promising therapeutic mechanism for the treatment of IBD (Jaiswal, 2004; Maloy and Powrie, 2011).